Explore PMOS Research
Search 20,749 PMOS papers published between 2015 and 2025. Filter by research topic, country, year range, or co-investigated condition to find where the field is active — and where the gaps are.
Total citations
289,983
Peak year
2025(3,021 articles)
Avg citations / article
14
Publications per year
Topics
All research areas ⓘArticle mentionsA paper tagged with multiple topics counts once in each. The Overview uses fractional counting instead. See methodology.
Countries
All countries
Top journals
All filters
Top institutions
All filters
Where in the world is each topic being researched?
Toggle between Revealed Comparative Advantage (RCA), a specialisation index where values above 1.0 mean a country focuses on that topic more than average, and raw article counts.
| Hormones | Metabolic | Fertility | Epidemiol. | Pharma | Diagnos. | Genetics | Mental | Nutrition | Molecular | Inflamm. | Cell Bio | Lifestyle | Microbiome | Dermatol. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China | 1.0 | 0.9 | 1.1 | 0.9 | 1.1 | 0.7 | 1.5 | 0.4 | 0.7 | 1.9 | 1.1 | 2.1 | 0.5 | 1.4 | 0.2 |
| United States | 1.0 | 1.1 | 1.0 | 1.3 | 0.8 | 1.1 | 0.9 | 1.4 | 0.6 | 0.6 | 0.7 | 0.6 | 1.0 | 0.6 | 1.3 |
| India | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.9 | 1.1 | 1.1 | 1.7 | 0.8 | 0.7 | 0.6 | 1.2 | 1.2 | 1.9 |
| Iran | 1.0 | 0.9 | 0.9 | 0.9 | 1.6 | 0.5 | 0.7 | 1.2 | 1.8 | 0.9 | 2.0 | 0.7 | 1.1 | 0.9 | 0.8 |
| Turkey | 1.2 | 1.2 | 0.8 | 0.4 | 0.4 | 1.4 | 0.5 | 1.0 | 1.0 | 0.6 | 1.7 | 0.5 | 0.4 | 1.3 | 1.4 |
| United Kingdom | 0.9 | 1.0 | 0.9 | 1.3 | 1.0 | 0.9 | 0.8 | 2.0 | 0.9 | 0.5 | 0.7 | 0.3 | 1.8 | 0.5 | 1.3 |
| Australia | 0.8 | 1.1 | 0.9 | 1.9 | 1.1 | 0.8 | 0.6 | 2.1 | 0.7 | 0.2 | 0.1 | 0.5 | 4.0 | 0.4 | 0.5 |
| Italy | 1.1 | 1.2 | 1.0 | 0.8 | 0.9 | 1.2 | 0.5 | 0.8 | 1.5 | 0.6 | 0.7 | 0.3 | 0.5 | 1.0 | 1.0 |
| Egypt | 1.0 | 0.8 | 1.9 | 0.4 | 1.7 | 0.8 | 0.4 | 0.6 | 1.1 | 0.6 | 1.0 | 0.5 | 0.3 | 0.3 | 2.2 |
| Poland | 1.3 | 1.4 | 0.5 | 0.6 | 0.4 | 0.8 | 0.6 | 1.2 | 0.8 | 0.6 | 1.2 | 0.4 | 1.1 | 1.7 | 1.6 |
Studies1,581–1,600 of 20,710
All studies
Effects of Genistein on polycystic ovary syndrome of rats: a systematic review and meta-analysis
Polycystic ovary syndrome: pragmatic management across levels of care
Review for "Metformin use in women with polycystic ovary syndrome (PCOS): Opportunities, benefits, and clinical challenges"
Effects of high basal luteinizing hormone levels on in vitro fertilization/intra-cytoplasmic injection outcomes in polycystic ovarian syndrome: a retrospective study.
Association of polycystic ovarian syndrome with inflammatory single nucleotide polymorphism for IL-1 & IL-6 genes: A case-control study.
Epitranscriptomic regulation via m6A RNA modification in PCOS pathophysiology.
Evaluation of Salivary Protein Carbonyl in Women with Polycystic Ovary Syndrome
Glycolysis in polycystic ovary syndrome: pathogenesis and treatment
Acetylation reader BRD4-driven TXNIP transcription enhances NLRP3 inflammasome activation in PCOS.
Pirfenidone reduces ovarian fibrosis and improves PCOS in letrozole-induced rat model.
Polycystic Ovary Syndrome Attenuates TSH-Lowering Effect of Metformin in Young Women with Subclinical Hypothyroidism
Interconnections Between the Immune System and Infertility in Women With Polycystic Ovary Syndrome: A Scoping Review Protocol
Reconsidering antral follicle changes in the DHEA-induced PCOS model: the overlooked role of AMH and methodological variability.
Assessment of Sonographic Ovarian Volume as a Potential Predictor of Polycystic Ovarian Syndrome (PCOS): A Hospital-Based Cross-Sectional Study.
Paratubal Cysts, Polycystic Ovary Syndrome, and Obesity in Adolescence: A Retrospective Cohort Study [ID 1696]
Evaluation of Insulin Resistance Markers in Polycystic Ovary Syndrome Patients Receiving Metformin, Finasteride or Both
Gremlin‐1 is associated with obesity but not polycystic ovary syndrome: Insights from a body mass index‐matched analysis of bone morphogenetic protein pathway components, a cross‐sectional study
MECHANISMS OF INTERRELATIONSHIP BETWEEN OBESITY AND DEVELOPMENT OF POLYCYSTIC OVARY SYNDROME
Autoimmune Diseases and the Risk of Polycystic Ovary Syndrome: Evidence from Mendelian Randomization and Multi-Omics Analysis
A revision of Traditional Chinese Medicine in the treatment of polycystic ovary syndrome: Utilizing data mining techniques for disease prevention and management